Cybin Inc (CYBN) SEC News Oct. 28, 2025, 12:10 UTC 0 0 comments New Form FWP - CYBIN INC. Filed: 2025-10-28 AccNo: 0001062993-25-016317 Size: 25 KB Comment Full text
Ecolab Inc (ECL) SEC News Oct. 28, 2025, 12:10 UTC 1 1 comments (100% Positive) ECOLAB INC. (ECL) Reports Q4 2025 Financial Results Comment Full text
AstraZeneca Plc (AZNCF) SEC News Oct. 28, 2025, 12:03 UTC 0 0 comments New Form 6-K - ASTRAZENECA PLC Filed: 2025-10-28 AccNo: 0001654954-25-012262 Size: 41 KB Comment Full text
Universal Health Services Inc (UHS) SEC News Oct. 28, 2025, 12:00 UTC 1 1 comments (30% Negative) UNIVERSAL HEALTH SERVICES, INC. (UHS) Reports Q4 2025 Financial Results Comment Full text
GSK plc (GLAXF) SEC News Oct. 28, 2025, 11:46 UTC 1 0 comments New Form 6-K - GSK plc Filed: 2025-10-28 AccNo: 0001654954-25-012261 Size: 1 MB Comment Full text
Edesa Biotech Inc (EDSA) SEC News Oct. 28, 2025, 11:45 UTC 1 1 comments (85% Positive) Edesa Biotech, Inc. (EDSA) Announces Clinical Development Update Comment Full text
Oncolytics Biotech Inc (ONCY) SEC News Oct. 28, 2025, 11:43 UTC 1 0 comments New Form 6-K - ONCOLYTICS BIOTECH INC Filed: 2025-10-28 AccNo: 0001129928-25-000084 Size: 41 KB Comment Full text
Kiniksa Pharmaceuticals (KNSA) SEC News Oct. 28, 2025, 11:39 UTC 1 1 comments (10% Negative) Kiniksa Pharmaceuticals International, plc (KNSA) Announces Delay in increase Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Adaptimmune Therapeutics plc (ADAP) SEC News Oct. 28, 2025, 11:30 UTC 1 0 comments New Form 25 - Adaptimmune Therapeutics PLC Filed: 2025-10-28 AccNo: 0001104659-25-102828 Size: 15 KB Comment Full text
Unicycive Therapeutics Inc. (UNCY) SEC News Oct. 28, 2025, 11:30 UTC 1 1 comments (10% Negative) Unicycive Therapeutics, Inc. (UNCY) Announces Clinical Trial Timeline Adjustment Comment Full text